Financial Statements · From SEC 10-K & 10-Q XBRL Filings
BrightSpring Health Services Revenue & Financial Statements
BrightSpring Health Services reported revenue of $12.9B for the fiscal year ended December 31, 2025, up 14.6% year over year, with net income of $189.1M and diluted EPS of $0.87.
- Company
- BrightSpring Health Services BTSG · NASDAQ
- Latest fiscal year
- FY ended Dec 31, 2025
- Statements
- Income · Balance Sheet · Cash Flow — 2 fiscal years, 8 quarters
Income Statement
Annual, as reported in 10-K filings. Values in USD.
| USD | FY2024 | FY2025 |
|---|---|---|
| Revenue | 11.3B | 12.9B |
| Cost of revenue | — | — |
| Gross profit | 1.6B | 1.5B |
| Operating income | 206.4M | 295.3M |
| Pretax income | 237K | 218K |
| Net income | (29.2M) | 189.1M |
| Diluted EPS | -0.09 | 0.87 |
| EBITDA | 296.1M | 459.5M |
Quarterly
| USD | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.6B | 2.7B | 2.9B | 3.1B | 2.9B | 3.1B | 3.3B | 3.6B |
| Cost of revenue | 2.2B | 2.3B | 2.5B | — | — | — | — | — |
| Gross profit | 369.4M | 389.0M | 408.1M | 421.9M | 338.4M | 374.9M | 392.0M | 412.5M |
| Operating income | 8.1M | 62.4M | 56.8M | 79.1M | 50.7M | 48.6M | 87.8M | 108.1M |
| Pretax income | (69.7M) | 10.0M | 779K | 24.2M | 9.0M | 9.8M | 49.6M | 69.6M |
| Net income | (35.2M) | 15.8M | (28.0M) | 18.1M | 26.3M | 25.7M | 53.9M | 77.3M |
| Diluted EPS | -0.26 | 0.10 | -0.04 | 0.09 | 0.14 | 0.13 | 0.26 | 0.35 |
| EBITDA | 57.0M | 112.5M | 107.4M | 133.9M | 92.9M | — | 128.6M | 147.6M |
Balance Sheet
Fiscal year-end snapshots. Values in USD.
| USD | FY2024 | FY2025 |
|---|---|---|
| Total assets | 5.9B | 6.4B |
| Current assets | 1.9B | 2.9B |
| Cash & equivalents | 61.3M | 88.4M |
| Total liabilities | 4.3B | 4.5B |
| Current liabilities | 1.4B | 1.8B |
| Long-term debt | 2.6B | 2.5B |
| Total debt | 2.6B | 2.5B |
| Stockholders’ equity | 1.6B | 1.9B |
| Net debt | 2.5B | 2.4B |
Cash Flow Statement
Annual, as reported in 10-K filings. Values in USD.
| USD | FY2024 | FY2025 |
|---|---|---|
| Operating cash flow | 23.8M | 490.2M |
| Investing cash flow | (140.2M) | (305.1M) |
| Financing cash flow | 164.6M | (157.9M) |
| Capital expenditure | 80.9M | 95.5M |
| Free cash flow | (57.1M) | 394.7M |
| Dividends paid | — | — |
| Stock-based compensation | 69.2M | 70.1M |
Figures are parsed from SEC XBRL company facts and may be derived where issuers report year-to-date values (quarterly figures differenced; Q4 computed as FY minus Q3). Fiscal periods follow each company's fiscal calendar, not calendar years. Historical fact, not investment advice — verify with official SEC filings.
Every BTSG filing, connected
Financials beside price, insider trades, and 8-K events — with alerts the moment something new is filed.